Navigation Links
Measles Vaccines Won't Raise Seizure Risk in Young Kids: Study

MONDAY, April 2 (HealthDay News) -- Measles vaccines don't increase the risk of febrile seizures in children ages 4 to 6, according to a new study.

Febrile seizures are brief, fever-related convulsions that are not fatal and do not lead to brain damage, epilepsy or other seizure disorders.

The study, conducted by the Kaiser Permanente Vaccine Study Center and funded by the U.S. Centers for Disease Control and Prevention, looked at data from nearly 87,000 children ages 48 to 83 months who received the measles-mumps-rubella-chickenpox (MMRV) vaccine; the MMR vaccine plus the varicella vaccine for chickenpox, administered separately but on the same day; or either the MMR or varicella vaccine alone.

There was no increased risk of febrile seizures among the children during the six weeks after they received any of the vaccinations, according to the study, which appears in the current issue of the journal Pediatrics.

"The results provide reassuring evidence that neither MMRV nor MMR plus V appear to be associated with an increased risk of post-vaccination febrile seizures in this 4-to-6 age group," lead author Dr. Nicola Klein, co-director of the Kaiser Permanente Vaccine Study Center, said in a news release.

In the United States, children receive two doses of MMR and varicella vaccines. The first is given between ages 1 and 2 and the second between ages 4 and 6.

A previous study found that children ages 1 to 2 who received the MMRV vaccine were twice as likely to have a febrile seizure seven to 10 days after vaccination than those who received MMR plus V.

The researchers noted that febrile seizures typically occur in children ages 6 months to 5 years, and the incidence of these seizures peaks at about 18 months of age.

"As febrile seizures are generally much less likely to occur among 4- to 6-year-old children, it is not surprising that we did not detect increased febrile seizures following MMRV or MMR plus V among 4- to 6-year-olds," Klein said.

"Families of 4- to 6-year-olds can be reassured from this study that the combination MMRV vaccine is safe," said Dr. Bruce Hirsch, associate chairman for clinical services at North Shore University Hospital in Manhasset, N.Y.

"Febrile seizures are scary; the child develops a high fever and convulses," he said. "The condition is surprisingly common and can occur after colds and other viral infections."

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about febrile seizures.

-- Robert Preidt

SOURCES: Bruce Hirsch, M.D., attending physician, Infectious Disease, North Shore University Hospital, Manhasset, N.Y.; Kaiser Permanente, news release, April 2, 2012

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers discover why measles spreads so quickly
2. Unvaccinated Kids Behind Largest U.S. Measles Outbreak in Years: Study
3. Decoding vaccination: Mayo researchers reveal genetic underpinnings of response to measles vaccine
4. Mayo Clinic physician: Mistaken fear of measles shot has devastating effect
5. Cell receptor could allow measles virus to target tumors
6. Measles outbreak underscores need for continued vigilance in health care settings
7. Measles not being reported
8. Travelers Bringing Measles Back to U.S., CDC Says
9. Scripps Research scientists find measles natural nemesis
10. Childhood Brain Tumors May Respond to Measles Virus
11. Infants Vulnerable to Measles Before 1st Shot
Post Your Comments:
Related Image:
Measles Vaccines Won't Raise Seizure Risk in Young Kids: Study
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: